Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

By Xu N.   Shen P.   Zhang X.   Yu L.   Bao H.   Shi G.   Huang S.   Chen J.   Mou H.   Fang W.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Benk J.   Chemaissani A.   Scholtze J.   Lorenz C.   Niestroy A.   Dalhoff K.   Muller T.   Walter T.   Durk H.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 583-590

Elsevier

Access to resources Recommend Favorite

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

By Zatloukal P.   Petruzelka L.   Zemanova M.   Kolek V.   Skrickova J.   Pesek M.   Fojtu H.   Grygarkova I.   Sixtova D.   Roubec J.   Horenkova E.   Havel L.   Prusa P.   Novakova L.   Skacel T.V.   Kuta M.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 321-331

Elsevier

Access to resources Recommend Favorite

Activity of Gemcitabine in Patients with Non-small Cell Lung Cancer: A Multicentre, Extended Phase II Study

By Gatzemeier U.   Shepherd F.A.   Le Chevalier T.   Weynants P.   Cottier B.   Groen H.J.M.   Rosso R.   Mattson K.   Cortes-Funes H.   Tonato M.   Burkes R.L.   Gottfried M.   Voi M.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 243-248

Elsevier

Access to resources Recommend Favorite